Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer

doi:10.4251/wjgo.v16.i3.833

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 3

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2604)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-5) series.

Item

Count

PDF

WORD

HTML

1302

Figures (1-2)

276

Tables (1-5)

264

Sum=1911

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

113

Download

505

Sum=618

Mar 15, 2024 (publication date) through Apr 28, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Oncology

ISSN

1948-5204

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Oncol. Mar 15, 2024; 16(3): 833-843
Published online Mar 15, 2024. doi: 10.4251/wjgo.v16.i3.833

Table 5 Prognostic factors of gastric remnant cancer based on COX proportional hazards model

Variable	B	SE	Wald	df	P value	HR	95%CI
LNR stage	0.499	0.122	16.755	1	0.000	1.647	1.297-2.092
Anemia	0.656	0.287	5.216	1	0.022	1.926	1.097-3.381
Serum tumor biomarkers level	0.612	0.293	4.365	1	0.037	1.844	1.039-3.275

B: Beta; SE: Standard error; df: Degree of freedom; HR: Hazard ratio; LNR: Lymph node ratio.

Citation: Zhuo M, Tian L, Han T, Liu TF, Lin XL, Xiao XY. Predictive value of positive lymph node ratio in patients with locally advanced gastric remnant cancer. World J Gastrointest Oncol 2024; 16(3): 833-843
URL: https://www.wjgnet.com/1948-5204/full/v16/i3/833.htm
DOI: https://dx.doi.org/10.4251/wjgo.v16.i3.833